These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28848924)

  • 1. Socioeconomic Status as a Determinant of Health Status Treatment Response in COPD Trials.
    Jones PW; Gelhorn H; Wilson H; Benson VS; Karlsson N; Menjoge S; Müllerova H; Rennard SI; Tal-Singer R; Merrill D; Tabberer M
    Chronic Obstr Pulm Dis; 2017 Apr; 4(2):150-158. PubMed ID: 28848924
    [No Abstract]   [Full Text] [Related]  

  • 2. Responder Analyses for Treatment Effects in COPD Using the St George's Respiratory Questionnaire.
    Jones PW; Gelhorn H; Wilson H; Karlsson N; Menjoge S; Müllerova H; Rennard SI; Tal-Singer R; Merrill D; Tabberer M
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):124-131. PubMed ID: 28848921
    [No Abstract]   [Full Text] [Related]  

  • 3. Baseline Severity as Predictor of Change in St George's Respiratory Questionnaire Scores in Trials of Long-acting Bronchodilators with COPD Patients.
    Jones PW; Gelhorn H; Karlsson N; Menjoge S; Müllerova H; Rennard SI; Tal-Singer R; Wilson H; Merrill D; Tabberer M
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):132-140. PubMed ID: 28848922
    [No Abstract]   [Full Text] [Related]  

  • 4. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional supplementation for stable chronic obstructive pulmonary disease.
    Ferreira IM; Brooks D; White J; Goldstein R
    Cochrane Database Syst Rev; 2012 Dec; 12():CD000998. PubMed ID: 23235577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
    Farne HA; Cates CJ
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. St George's Respiratory Questionnaire Score Predicts Outcomes in Patients with COPD: Analysis of Individual Patient Data in the COPD Biomarkers Qualification Consortium Database.
    Müllerova H; Gelhorn H; Wilson H; Benson VS; Karlsson N; Menjoge S; Rennard SI; Tabberer M; Tal-Singer R; Merrill D; Jones PW
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):141-149. PubMed ID: 28848923
    [No Abstract]   [Full Text] [Related]  

  • 8. The COPD Biomarkers Qualification Consortium Database: Baseline Characteristics of the St George's Respiratory Questionnaire Dataset.
    Tabberer M; Benson VS; Gelhorn H; Wilson H; Karlsson N; Müllerova H; Menjoge S; Rennard SI; Tal-Singer R; Merrill D; Jones PW
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):112-123. PubMed ID: 28848920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools.
    Alma HJ; de Jong C; Jelusic D; Wittmann M; Schuler M; Kollen BJ; Sanderman R; Schultz K; Kocks JWH; Van der Molen T
    Health Qual Life Outcomes; 2018 Jun; 16(1):130. PubMed ID: 29940980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline health status and setting impacted minimal clinically important differences in COPD: an exploratory study.
    Alma H; de Jong C; Jelusic D; Wittmann M; Schuler M; Kollen B; Sanderman R; Kocks J; Schultz K; van der Molen T
    J Clin Epidemiol; 2019 Dec; 116():49-61. PubMed ID: 31362055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Appleton S; Smith B; Veale A; Bara A
    Cochrane Database Syst Rev; 2000; (2):CD001104. PubMed ID: 10796594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing efficacy of indacaterol in moderate and severe COPD patients: a 12-week study in an Asian population.
    To Y; Kinoshita M; Lee SH; Hang LW; Ichinose M; Fukuchi Y; Kitawaki T; Okino N; Prasad N; Lawrence D; Kramer B
    Respir Med; 2012 Dec; 106(12):1715-21. PubMed ID: 23040786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.
    Rutten-van Mölken MP; van Nooten FE; Lindemann M; Caeser M; Calverley PM
    Pharmacoeconomics; 2007; 25(8):695-711. PubMed ID: 17640111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD.
    Jones PW; Mahler DA; Gale R; Owen R; Kramer B
    Respir Med; 2011 Jun; 105(6):892-9. PubMed ID: 21397482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistent improvement in health-related quality of life with tiotropium in patients with chronic obstructive pulmonary disease: Novel and conventional responder analyses.
    Tashkin DP; Bateman ED; Jones P; Zubek VB; Metzdorf N; Liu D; Leonard T; Clerisme-Beaty E; Wise RA
    Respir Med; 2016 Nov; 120():91-100. PubMed ID: 27817821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health status instruments for patients with COPD in pulmonary rehabilitation: defining a minimal clinically important difference.
    Alma H; de Jong C; Jelusic D; Wittmann M; Schuler M; Flokstra-de Blok B; Kocks J; Schultz K; van der Molen T
    NPJ Prim Care Respir Med; 2016 Sep; 26():16041. PubMed ID: 27597571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled corticosteroids for stable chronic obstructive pulmonary disease.
    Yang IA; Fong KM; Sim EH; Black PN; Lasserson TJ
    Cochrane Database Syst Rev; 2007 Apr; (2):CD002991. PubMed ID: 17443520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.